Scientific Sessions 2025  /  Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy  /  Case Presentation: Low-Risk Young (50-60 Years Old) Patient with Severe Symptomatic Aortic Stenosis
Logo

American Heart Association

  36
  0

Final ID:

Case Presentation: Low-Risk Young (50-60 Years Old) Patient with Severe Symptomatic Aortic Stenosis

  • Hamilton, Barbara  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Scrimgeour, Laura  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Bromberger, Bianca  ( UCSF , Boston , Massachusetts , United States )
  • Boskovski, Marko  ( UCSF , Boston , Massachusetts , United States )
    • Author Disclosures:
    Barbara Hamilton: DO NOT have relevant financial relationships | Laura Scrimgeour: DO NOT have relevant financial relationships | Bianca Bromberger: No Answer | Marko Boskovski: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Is TAVR Increasing in the Young and What are the Outcomes?

Forcillo Jessica, Eltchaninoff Helene, Preventza Ourania, Ouzounian Maral

TAVR for All Patients

Hahn Rebecca, Genereux Philippe, Makkar Raj, Mehran Roxana, Tchetche Didier, Webb John

More abstracts from these authors:
Case Presentation: TAVR Degeneration in an Intermediate-Risk Patient

Hamilton Barbara, Scrimgeour Laura, Bromberger Bianca

Case Presentation: LIfetime Management in 65-79 Year Olds

Hamilton Barbara, Scrimgeour Laura, Bromberger Bianca

You have to be authorized to contact abstract author. Please, Login
Not Available